Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 1688-1693, June 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, K. L.
Right arrow Articles by Addison, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, K. L.
Right arrow Articles by Addison, J.

Glucocorticoid-induced Growth Inhibition of Cells from a Human Lung Alveolar Cell Carcinoma1

Kenneth Lee Jones2, Norman S. Anderson, III and Judith Addison

University of California, San Diego School of Medicine, Departments of Pediatrics [K. L. J., J. A.] and Medicine [N. S. A.], La Jolla, California 92093

We have studied the effects of dexamethasone on cell growth and DNA synthesis in the A549 cell line, a line that was originally isolated from a human alveolar carcinoma. Dexamethasone at a concentration of 10-9 M inhibited growth of these cells. Maximal growth inhibition was seen with 4 x 10-8 M dexamethasone (44% of control). The population-doubling time of the cells increased from 28.4 hr under control conditions to 66.5 hr with dexamethasone treatment. Dexamethasone also inhibited DNA synthesis within the same concentration range that inhibited cell growth. Decreased [3H]thymidine incorporation was observed as early as 6 hr after steroid addition. Inhibition of growth and DNA synthesis by other steroids was observed and was of the order: dexamethasone > cortisol > corticosterone > deoxycortisone. Testosterone and estradiol were not inhibitory. The cells were also examined for presumptive evidence of cytoplasmic [3H]dexamethasone receptors. Specific binding of [3H]dexamethasone was observed, and Scatchard analysis of the data revealed that Kd equalled 7.1 x 10-9 M. The ability of other steroids to decrease the binding of [3H]dexamethasone was related to their ability to inhibit A549 cell growth and their biological activity as glucocorticoids. We feel that the A549 cell line will provide a system in which to study a pattern of glucocorticoid-induced growth inhibition that is not associated with marked catabolic effects and cell lysis and that may provide a model for the study of the relationship of steroid-induced differentiation to growth.

1 Supported by NIH Grants HL 17565, CA 15796, and CA 02837. These data were presented in part at the 28th Annual Meeting of the Tissue Culture Association in June 1977 (2).

2 To whom requests for reprints should be addressed, at University of California, San Diego School of Medicine, Department of Pediatrics, M-009, La Jolla, Calif. 92093.

Received 8/ 5/77. Accepted 3/ 1/78.




This article has been cited by other articles:


Home page
ScienceHome page
F Sweet, M. Kao, S. Lee, W. Hagar, and W. Sweet
Ozone selectively inhibits growth of human cancer cells
Science, August 22, 1980; 209(4459): 931 - 933.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.